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ABSTRACT  
Objective: To determine the frequency and pattern of abnormal cervical smear findings among women attend-
ing the University of Science and Technology Hospital (USTH) in Sana'a city. 
Methods: This study is a retrospective, cross-sectional study. Records of women examined by conventional Pap 
smears in the Histopathology Laboratory of USTH over a 4-year period (from January 2013 to December 2016) 
were retrieved and analyzed for abnormalities according to the Bethesda system. 
Results: Of 688 cases, 599 with satisfactory records were analyzed. The mean age of the cases was 39.18±10.23 
years (range: 19–75). Epithelial cell abnormalities (ECAs) were found in 47 cases (7.8%), and these were cate-
gorized as follows: ASCUS in 4.5% (27/599) of cases followed by atypical glandular cells (AGC) (2.2%; 13/599) 
and LSIL (0.5%; 3/599), while ASCH and HSIL abnormalities were equally observed among 0.3% (2/599 each) 
of cases. Of patients positive Pap smear findings, ASCUS was the most frequent type of ECA (57.4%; 27/47) fol-
lowed by AGC (27.7%; 13/47) and LSIL (6.4%; 3/47), while ASCH and HSIL were the least frequent ECAs among 
Yemeni patients. ECAs were significantly more prevalent among women aged >40 years (10.8%) compared with 
those aged <40 years (5.5%). 
Conclusions: Cervical cytological abnormalities are not uncommon among women in Yemen, where the AGC is 
frequent among about a third of women with abnormal Pap smear findings and affects women of different ages. 
This requires more attention and training of doctors to master good sample taking, preparation and diagnosis 
with a focus on glandular changes. 
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1. Introduction 
Cervical cancer is considered as the fourth lead-
ing cause of female cancers worldwide. More 
than 528,000 new cases were estimated in 
2012, of which about 86% occurred in the least 
developed countries. Moreover, approximately 
266,000 females died of cervical cancer, repre-
senting 7.5% of all female cancer deaths (1). In 
developing countries, cervical cancer is the se-
cond most frequently diagnosed cancer after 
breast cancer and the third leading cause of 
cancer death after breast and lung cancers (1). 
Its highest incidence rates are in Eastern Africa, 
while its lowest rates are in Western Asia (1). 
Such a variation may reflect differences in pre-
disposing risk factors, prevalence of human 
papillomavirus (HPV) infection as well as the 
use of screening and diagnostic methods (1–3). 
Infection with HPV is the main risk factor 
for cervical cancer, which is believed to have a 
causal role in all of cervical cancer cases (4). 
Although more than a hundred HPV types have 
been identified, only some types can cause cer-
vical cancer. HPV 16 and 18 are the most com-
mon subtypes identified in cervical cancer, 
where they account for about 70% of cervical 
cancers worldwide (5). Nevertheless, cervical 
cancer is preventable if precancerous lesions 
are diagnosed early by Pap smear screening 
and subsequently treated. Pap smear screening 
remains an effective and widely used method 
for early detection of pre-cancer and cervical 
cancer. This test may also detect infections and 
abnormalities in the endocervix and endome-
trium (6). 
Cervical cancer is more common among 
women not undergoing regular cervical cyto-
logical tests. Squamous cell carcinoma was 3.9 
and 13 times more in women screened once 
every three and ten years, respectively, com-
pared with those screened annually(7). 
In Yemen, 8.5 million women aged 15 years 
or older are at risk of developing cervical cancer. 
It is estimated that 198 women are diagnosed 
with cervical cancer and 117 die from the dis-
ease each year. Cervical cancer in the country 
ranks as the ninth most frequent cancer among 
women and the tenth most frequent cancer 
among women aged 15–44 years (8). However, 
there is no effective cervical screening program 
for early detection of invasive cervical neoplasia 
and for starting appropriate management to re-
duce female mortality rates due to cervical can-
cer. This plays a risky role in the prognosis of 
cervical cancer. 
Data on the cervical cytological abnormali-
ties in Yemen are not available (9). Therefore, 
this study is the first to report on abnormal cer-
vical Pap smear findings among Yemeni women. 
It aimed to determine the frequency and pattern 
of abnormal cervical smear findings in relation 
to age among women attending the University of 
Science and Technology Hospital (USTH), a ter-
tiary care hospital based at Sana'a, Yemen.  
2. Methods 
2.1 Study design and categorization of smear 
findings 
 
This study is a retrospective, cross-sectional 
study. Records of women examined by conven-
tional Pap smears in the Histopathology Labora-
tory of the USTH over a 4-year period (from Jan-
uary 2013 to December 2016) were retrieved 
and analyzed for abnormalities according to The 
Bethesda System (TBS) (10). 
Unsatisfactory cytology reports were ex-
cluded. The included smears were those with 
very few epithelial cells or where the morpholo-
gy of the cells was obscured by blood or severe 
inflammation according to the guidelines of TBS 
(10). The following categories were used: nega-
tive for intraepithelial lesions or malignancy 
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(NILM), atypical squamous cells of undeter-
mined significance (ASCUS), ASCUS results with 
possible HSIL (ASC-H), low-grade squamous in-
traepithelial lesions (LSILs), high-grade squa-
mous intraepithelial lesions (HSILs) and atypi-
cal glandular cells (AGCs) and carcinomas. 
2.2. Statistical analysis  
 
Data were analyzed using the IBM SPSS Statis-
tics, version 21.0 (IBM Corp., Chicago, IL, USA). 
Descriptive statistics were presented as fre-
quencies, percentages or means ± standard de-
viations. Chi-square test was used to determine 
significant differences between the proportions 
of age groups, where two-tailed P value <0.05 
was considered statistically significant.  
3. Results 
Of 688 cases, 599 satisfactory cases (87%) were 
analyzed and 89 cases (13 %) with unsatisfacto-
ry reports were excluded. The average age of the 
599 satisfactory cases was 39.2 ± 10.2, ranging 
from 19 to 75 years. However, the age of cases 
with epithelial cell abnormalities was between 
22 and 71 years, with the mean age being 43.11 
years±11.12. As shown in Table (1), the majority 
of women screened by Pap smear for cervical 
cancer were in the age group of 30–39 years, fol-
lowed by those belonging to the 40–49 age 
groups, while those aged ≥60 years were the 
least frequent.  
Table (2) shows that the epithelial cell ab-
normalities (ECAs) were found in 7.8% 
(47/599) of cases, which were distributed as 
follows: ASCUS in 4.5% (27/599) of cases fol-
lowed by AGC (2.2; 13/599) and LSIL (0.5%; 
3/599). However, ASCH and HSIL abnormalities 
were equally observed among 0.3% (2/599) of 
cases each. On the other hand, Figure (1) shows 
that ASCUS was the most frequent type of ECAs 
(57.4%/ 27/47) followed by AGC (27.7%; 
13/47) and LSIL (6.4%; 3/47), while ASCH and 
HSIL were the least frequent ECAs among Yem-
eni patients. 
Table 1. Age distribution of women undergoing Pap smear screen-
ing in the USTH in Sana’a in the period 2012–2016 
Age category  n (%) 
<30 113 (18.9) 
30–39 217 (36.2) 
40–49 160 (26.7) 
50–59 97 (16.2) 
≥60 12 (2.0) 
Total 599 (100) 
ASCUS, abnormal squamous cells of undetermined significance; 
ASCH, abnormal squamous cells-high grade cannot be excluded; 
LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade 
squamous intraepithelial lesion; AGC, atypical glandular cells. 
 
Table 2. Frequency of epithelial cell abnormalities using the re-
vised Bethesda system among the study population (N=599) 
 
ASCUS, abnormal squamous cells of undetermined significance; 
ASCH, abnormal squamous cells-high grade cannot be excluded; 
LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade 
squamous intraepithelial lesion; AGC, atypical glandular cells. 
 
 
Table (3) shows that ECAs were more preva-
lent among women aged ≥ 40 years (10.8%) 
compared to those < 40 years (5.5%), with a sta-
tistically significant difference (χ2 = 5.81, P = 
0.016). However, there was no statistically sig-
nificant difference for AGC according to age (χ2 
= 1.49, P = 0.22). 
Epithelial cell abnormalities 
 
n (%) Mean age 
(years) 
ASCUS 27 (4.5) 42 ± 13.3 
ASCH 2 (0.3) 48 ± 1.4 
HSIL 2 (0.3) 45 ± 0.0 
LSIL 3 (0.5) 45 ± 8.7 
AGC 13(2.2) 43.9 ± 8.4 
Total 47 (7.8) 43.1 ± 11.1 
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Figure 1. Pattern of Epithelial cell abnormalities among women 
attending a tertiary health care hospital in Sana’a city (2012–
2016) 
Table 3. Comparison of epithelial cell abnormalities and atypical 
glandular cells among women with abnormal Pap smear findings 
in Sana’a according to age 
Age 
group 
 
N 
Type of abnormalities 
ECA AGC 
n (%) χ2 (P value) n (%) χ2 (P value) 
<40  330 18 (5.5) 5.81  
(0.016*) 
5 (1.5) 1.49 
(0.220) ≥40  269 29 (10.8) 8 (3.0) 
Total  599 47 (7.8) 13 (2.2) 
ECA, epithelial cell abnormalities; AGC, atypical glandular cells; * 
statistically significant at P <0.05. 
4. Discussion 
The overall frequency of ECAs among Yemeni 
women based on TBS classification of Pap 
smear findings in our study was 7.8%. This re-
sult is relatively higher than those found in 
many Arab countries including the UAE (11, 
12), Kuwait (13), some regions of Saudi Arabia 
(14–16), Alexandria, Egypt (17) and Jordan 
(18). However, it is very close to those reported 
from southwestern Saudi Arabia (7.9%) (19) 
and Egypt (7.8%) (20). On the other hand, it is 
lower than those reported by some studies 
from Iraq (19.7%) (21), western Saudi Arabia 
(17.3%) (22) and Nablus, Palestine (11.9%) 
(23).  
 The significantly higher prevalence of 
ECA among women aged 40 years and older in 
our study is in agreement with previous studies 
that found a relationship between age and ECA 
(24, 25).  
In the present study, ASCUS was the most 
prevalent ECA type (57.4%), and this is in ac-
cordance with the findings of many other stud-
ies in Arab (11–13, 18–20, 23) and non-Arab 
countries (24, 26–29) On the other hand, the 
current study revealed that AGCs are not un-
common in Yemeni women since they represent 
about one-third of all ECAs among studied 
women. This finding is consistent with the ma-
jority of studies in the Arab region (13, 18–23). 
Moreover, because cytology-based screening has 
a relatively lower sensitivity for the detection of 
early glandular lesions than for the squamous-
cell cancer precursors (30), the prevalence rate 
of AGC is expected to be higher than what was 
found in our study.  
The high prevalence of AGC in our study re-
quires attention and further studies because of 
its clinical importance as the percentage of cases 
associated with an underlying high-grade dis-
ease is higher than for ASCUS (10). According to 
follow-up studies, high-grade lesions (either 
squamous or glandular) may be seen in 10–39% 
of such cases (10). 
On comparing the results of several studies 
from Arab countries (13, 18–23), including 
those of the present study, with those from non-
Arab countries (24–27), the frequency of AGC is 
much higher in the Arab countries. This, in turn, 
requires more emphasis, further studies and fol-
low-up.  
In a study on the trend of the cellular chang-
es during a period of 21 years (between 1992 
and 2012) in Kuwait, Kapila et al. (13) noted a 
significant increase in the number of glandular 
changes. On the other hand, a recent study in 
Saudi Arabia stressed the need to focus more on 
glandular abnormalities (15).  
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Several studies reported increasing rates of 
adenocarcinoma among younger women, par-
ticularly under the age of 40 (31–35). This is in 
accordance with the finding of the present 
study that AGC affects both of women younger 
than 40 years and older. However, there was no 
statistically significant difference according to 
age.  
Regarding the HSIL that has emerged as the 
central purpose of cervical cytology screening 
(10), the frequency in the present study was 
0.3%. This frequency is one of the lowest fre-
quencies in the Arab region and the world. In 
Arab countries, it was 5% in Iraq (21), 1.0% in 
Kuwait (13), 0.7–0.9% in Saudi Arabia (14, 16, 
19, 22), and 0.8% in the United Arab Emirates 
(11, 12). However, in non-Arab counties, it was 
1.8% in Bangladesh (25) and 1. 9% in South Af-
rica (27). Since HSIL is associated with HPV 
persistence and higher risk for progression 
(10), the low prevalence of HSIL in our study 
may suggest that the existence of squamous le-
sions caused by HPV is not common in our pop-
ulation.  
This study is limited by being hospital-
based among women referred for screening 
based on a gynecological indication. Therefore, 
the results may not reflect the true estimates of 
abnormal cytological findings among Yemeni 
women in all parts of the country.  
5. Conclusions 
Cytological cervical abnormalities are relatively 
common among women in Yemen. The AGCs 
are more prevalent than squamous intraepithe-
lial lesions, affecting women of different ages. 
This requires more attention and training of 
physicians to master good sampling, prepara-
tion and diagnosis with a focus on glandular 
changes.  
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